GE HealthCare expands mammography deal with RadNet's DeepHealth to broaden global access to AI breast cancer screening tools

GE HealthCare and DeepHealth expanded their AI mammography partnership April 17, adding two tools that raised cancer detection rates 21% in the largest real-world U.S. study. Detection improved 23% for women with dense breast tissue.

Categorized in: AI News Healthcare
Published on: Apr 17, 2026
GE HealthCare expands mammography deal with RadNet's DeepHealth to broaden global access to AI breast cancer screening tools

GE HealthCare expands AI mammography tools with DeepHealth partnership

GE HealthCare and DeepHealth, a RadNet subsidiary, announced an expanded collaboration on April 17 to distribute AI-powered breast cancer screening software globally. The deal extends a 2024 joint initiative pairing DeepHealth's screening algorithms with GE HealthCare's Senographe Pristina mammography systems.

The expanded offering includes two new applications: ProFound Pro, which automatically detects lesions and assesses breast density, and Safeguard Review, an optional workflow that flags complex cases for secondary review. Both integrate with GE HealthCare's Pristina Via mammography system.

Clinical performance data

In the largest real-world U.S. analysis of AI-driven breast cancer screening, the multistage workflow increased cancer detection rates by 21% compared to standard care. For women with dense breast tissue, detection rates rose 23%.

DeepHealth's Timely Alerts feature notifies clinics of potentially suspicious cases within minutes. The cloud-based system integrates directly into existing mammography workflows without disrupting operations.

What the tools do

ProFound Pro combines two functions. Cancer Detection uses AI to automatically locate lesions and assign suspicion scores across diverse populations and dense tissue. Automated Density Assessment provides consistent, objective density classification for 2D and 3D mammograms.

Safeguard Review flags cases that may benefit from a radiologist's second opinion, reducing missed diagnoses. The larger Breast Suite also includes a cloud-based viewer, prioritized worklists, and structured reporting.

Additional announcements at SBI 2026

GE HealthCare showcased additional breast imaging technology at the Society of Breast Imaging Annual Symposium. Pristina Recon DL, a new 3D mammography reconstruction technology, uses deep learning models to reduce noise and artifacts while maintaining image sharpness without increasing patient dose.

The company also displayed Invenia ABUS Prime, an automated breast ultrasound system for supplemental screening in women with dense breasts. The system is designed for multi-site deployment across breast imaging networks.

LOGIQ Series ultrasound systems feature AI-enabled workflow tools to streamline lesion assessment and reduce exam time.

Clinical perspective

Dr. Meghna Krishnan, owner of URPrecious Imaging in Arizona, said the combination of Pristina Via and Breast Suite changed her clinic's workflow. "The cloud-based viewer gives us instant access to images from anywhere, and the AI tools can help us deliver fast and consistent results," she said. "It's not just about speed, it's about confidence."

For healthcare IT leaders and radiologists evaluating AI screening tools, the published detection rate improvements and workflow integration specifics provide concrete performance metrics rather than general claims. The cloud-first architecture addresses operational concerns around system deployment and image accessibility.

Learn more about AI for Healthcare applications in clinical settings.


Get Daily AI News

Your membership also unlocks:

700+ AI Courses
700+ Certifications
Personalized AI Learning Plan
6500+ AI Tools (no Ads)
Daily AI News by job industry (no Ads)